e-learning
resources
ERJ
2002
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhibition of granulocyte activation by surfactant in a 2-yr-old female with meningococcus-induced ARDS
Tegtmeyer F.K., Moller J., Zabel P.
Source:
Eur Respir J 2002; 19: 776-779
Journal Issue:
April
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tegtmeyer F.K., Moller J., Zabel P.. Inhibition of granulocyte activation by surfactant in a 2-yr-old female with meningococcus-induced ARDS. Eur Respir J 2002; 19: 776-779
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Risk factors associated with the development of interstitial lung abnormalities
Acute respiratory distress syndrome
Related content which might interest you:
Recovery of neutrophil apoptosis by ectoine: a new strategy against lung inflammation
Source: Eur Respir J 2013; 41: 433-442
Year: 2013
Inhibition of neutrophil elastase contributes to attenuationof lipopolysaccharide-induced acute lung injuryduring neutropenia recovery in mice
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
Increased vascular endothelial growth factor in acute eosinophilic pneumonia
Source: Eur Respir J 2003; 21: 774-778
Year: 2003
Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients
Source: Eur Respir J 2007; 30: 701-707
Year: 2007
The effect of sputum processing on tumour necrosis factor (TNFα), secretory leukoprotease inhibitor (SLPI), interleukin-6 and leukotriene-B4 (LTB
4
) in chronic bronchitis and bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 364s
Year: 2001
Eotaxin and monocyte chemoattractant protein-1 in chronic eosinophilic pneumonia
Source: Eur Respir J 2001; 17: 962-968
Year: 2001
Monocyte chemotactic protein-1 in the migration of differentiated leukaemic cells toward alveolar epithelial cells
Source: Eur Respir J 2008; 31: 957-962
Year: 2008
Erythropoietin inhibits respiratory epithelial cell apoptosis in a model of acute lung injury
Source: Eur Respir J 2009; 33: 1403-1414
Year: 2009
Usefulness of a selective neutrophil elastase inhibitor and a recombinant human soluble thrombomodulin in patients with ARDS and DIC
Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Year: 2013
Severe neonatal acute pneumonia correlates with histological chorioamnionitis and raised concentrations of interleukin 6 (IL6), IL8 and c-reactive protein
Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection
Year: 2009
A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice
Source: Eur Respir J 2012; 40: 1475-1482
Year: 2012
Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs
Source: Eur Respir J 2007; 29: 1105-1114
Year: 2007
Regulation, cell-specific expression and metabolism of factor VII activating protease (FSAP) in lungs from patients with acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006
Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis
Source: Eur Respir J 2004; 23: 106-112
Year: 2004
β-Adrenoceptor stimulation and neutrophil accumulation in mouse airways
Source: Eur Respir J 2004; 24: 231-237
Year: 2004
Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis
Source: Eur Respir J 2003 Dec 01;22(6):895-899
Year: 2003
Regulation of vascular endothelial growth factor expression in a mouse model of acute respiratory distress syndrome (ARDS)
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease
Source: Eur Respir J 2006 Oct 01;28(4):824-831
Year: 2006
Plasmapheresis for treatment of pulmonary alveolar proteinosis
Source: Eur Respir J 2009; 33: 1220-1222
Year: 2009
Mesenchymal stromal cells (MSC) anti-microbial effect in acute respiratory distress syndrome (ARDS) is mediated in part by enhanced alveolar macrophage phagocytosis through cell contact-dependent mitochondrial transfer leading to improved macrophage bioenergetics
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept